MedPath

STCube, Inc.

STCube, Inc. logo
🇰🇷South Korea
Ownership
Public
Established
1989-01-01
Employees
51
Market Cap
-
Website
http://www.stcube.com

Clinical Trials

3

Active:0
Completed:1

Trial Phases

1 Phases

Phase 1:3

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (3 trials with phase data)• Click on a phase to view related trials

Phase 1
3 (100.0%)

Nelmastobart in Combination With Trifluridine/ Tipiracil and Bevacizumab in Metastatic/ Recurrent Colorectal Cancer

Phase 1
Recruiting
Conditions
Metastatic Colorectal Cancer (CRC)
Recurrent Colorectal Cancer
Interventions
Drug: Nelmastobart 800 mg+Trifluridine/Tipiracil+ Bevacizumab
First Posted Date
2025-03-13
Last Posted Date
2025-07-11
Lead Sponsor
STCube, Inc.
Target Recruit Count
52
Registration Number
NCT06873763
Locations
🇰🇷

Seoul National University Bundang Hospital, Seongnam-si, Gyeonggi-do, Korea, Republic of

🇰🇷

Seoul National University Hospital, Seoul, KR, Korea, Republic of

🇰🇷

Severance Hospital, Seoul, KR, Korea, Republic of

and more 2 locations

A Study of hSTC810 in Combination With Paclitaxel in Relapsed or Refractory Extensive Stage Small Cell Lung Cancer

Phase 1
Recruiting
Conditions
Extensive Stage Small Cell Lung Cancer
Interventions
Drug: hSTC810 400 mg + Paclitaxel
Drug: hSTC810 800 mg + Paclitaxel
First Posted Date
2023-08-29
Last Posted Date
2024-02-22
Lead Sponsor
STCube, Inc.
Target Recruit Count
130
Registration Number
NCT06016270
Locations
🇺🇸

Tisch Cancer Institute at Mount Sinai, New York, New York, United States

🇺🇸

MD Anderson Cancer Center, Houston, Texas, United States

🇰🇷

Korea University Anam Hospital, Seoul, Korea, Republic of

and more 5 locations

A Study of hSTC810 With Advanced/Metastatic Solid Tumors (STCUBE-001)

Phase 1
Completed
Conditions
Advanced Solid Tumor
First Posted Date
2022-02-09
Last Posted Date
2024-03-13
Lead Sponsor
STCube, Inc.
Target Recruit Count
47
Registration Number
NCT05231746
Locations
🇺🇸

Yale Cancer Center, New Haven, Connecticut, United States

🇺🇸

Mount Sinai Hospital, New York, New York, United States

🇺🇸

MD Anderson Cancer Center, Houston, Texas, United States

and more 2 locations

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.